一种有前途的天然抗癌化合物,来自Gymnoascus dankaliensis
1Department of Biology, College of Science, University of Basrah, Basrah, Iraq.
Archives of Razi Institute
|July 3, 2023
概括
来自真菌Gymnoascus dankaliensis (G. dankaliensis) 的天然化合物显示出抗癌潜力. 提取物抑制了特定癌症细胞系的生长,这表明了有前途的新治疗途径.
科学领域:
- 菌类学 菌类学是指菌类学.
- 自然产品化学 自然产品化学
- 癌症生物学 癌症生物学
背景情况:
- 癌症仍然是导致死亡的主要原因,没有确定的治疗方法.
- 从真菌等生物体中获得自然化合物的研究为新的癌症治疗提供了潜在的潜力.
研究的目的:
- 从真菌Gymnoascus dankaliensis (G. dankaliensis) 中分离和描述二次代谢产物 (SM).
- 评估这些天然产品对SR和HCT-18 (HRT-18) 细胞系的抗癌活性.
主要方法:
- G. dankaliensis从便样本中分离出来,并通过分子方法 (ITS测序) 来识别.
- 在大米介质上进行固态发酵,用于通过乙酸乙烯提取代谢物.
- 气色谱-质谱 (GC-MS) 分析了提取的化合物.
主要成果:
- G. dankaliensis产生了一种含有五种化合物的二次代谢物提取物.
- 提取物在27小时后显著抑制了SR和HCT-8细胞系生长.
- 半最大抑制度 (IC50) 为HCT-18的3.57微克/毫升,SR细胞的8.61微克/毫升.
结论:
- 来自G. dankaliensis的天然提取物对经过测试的细胞系表现出显著的抗癌活性.
- 这些发现强调了G. dankaliensis二次代谢物的潜力,作为开发新抗癌疗法的基础.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.6K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
205
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
205
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
